Literature DB >> 24758417

Modulation of endothelial function by Korean red ginseng (Panax ginseng C.A. Meyer) and its components in healthy individuals: a randomized controlled trial.

Elena Jovanovski1, Valentina Peeva, John L Sievenpiper, Alexandra L Jenkins, Leanne Desouza, Dario Rahelic, Mi-Kyung Sung, Vladimir Vuksan.   

Abstract

AIMS: Ginseng root and its derivatives remain atop the most widely used medicinal herbs in cardiovascular disease, despite inadequate substantiation of efficacy. We previously reported the potential of Korean red ginseng (KRG) to affect vascular tone by decreasing arterial wave reflection via an unknown mechanism. Given the preclinical link between ginseng intake and vasoactivity related to nitric oxide (NO) production, we sought to directly evaluate the effects of KRG root and its major root components, on an established noninvasive measure of endothelial function.
METHODS: In an acute, randomized, placebo-controlled, double-blind, crossover design, 16 healthy participants (9M:7F, age:30 ± 9y, BMI: 24 kg ±3 kg/m(2) , systolicBP/diastolicBP: 109 ± 11/66 ± 8 mmHg) on four occasions were administered: KRG root (3 g), KRG ginsenosides extract, KRG polysaccharides extract, and cornstarch control. Extracted fractions were delivered at doses bioequivalent to those found in 3 g of KRG. Flow-mediated vasodilatation (FMD) assessment, preceding a brachial blood pressure measurement, was performed at baseline and at 90 and 180 min posttreatment to assess endothelial function.
RESULTS: KRG significantly improved FMD posttreatment. Maximal vasodilatation of Δ2.57 ± 2.8% occurred at 180 min compared with control (Δ-0.83 ± 2.7%, P = 0.003 for all comparisons). The ginsenoside extract produced a comparable response (Δ1.75 ± 2.6%), but not the polysaccharide fraction (Δ0.10 ± 2.7%). Brachial blood pressure remained unchanged for all treatments (P = 0.45).
CONCLUSIONS: KRG acutely improved endothelial function in healthy individuals, which appears to be attributable to its ginsenoside containing fraction. Our data confirm preclinical data and support the potential for these compounds as targets for therapeutic strategies in disorders involving endothelial dysfunction.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Clinical trial; Endothelial function; Flow-mediated dilation; Ginseng

Mesh:

Substances:

Year:  2014        PMID: 24758417     DOI: 10.1111/1755-5922.12077

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  8 in total

1.  Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects.

Authors:  Tae Woong Cha; Minjoo Kim; Minkyung Kim; Jey Sook Chae; Jong Ho Lee
Journal:  Hypertens Res       Date:  2016-02-04       Impact factor: 3.872

Review 2.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

3.  Korean Red Ginseng saponin fraction exerts anti-inflammatory effects by targeting the NF-κB and AP-1 pathways.

Authors:  Jeong-Oog Lee; Yanyan Yang; Yu Tao; Young-Su Yi; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2022-02-24       Impact factor: 5.735

4.  Rg3-enriched Korean Red Ginseng enhances blood pressure stability in spontaneously hypertensive rats.

Authors:  Harsha Nagar; Sujeong Choi; Saet-Byel Jung; Byeong Hwa Jeon; Cuk-Seong Kim
Journal:  Integr Med Res       Date:  2016-06-03

5.  Induction of Thioredoxin Reductase 1 by Korean Red Ginseng Water Extract Regulates Cytoprotective Effects on Human Endothelial Cells.

Authors:  Hye Rim Park; Seung Eun Lee; Hana Yang; Gun Woo Son; Young-Ho Jin; Yong Seek Park
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-08       Impact factor: 2.629

Review 6.  Ginseng: An Nonnegligible Natural Remedy for Healthy Aging.

Authors:  Yong Yang; Changhong Ren; Yuan Zhang; XiaoDan Wu
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

7.  Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study.

Authors:  V Welch; M Doull; M Yoganathan; J Jull; M Boscoe; S E Coen; Z Marshall; J Pardo Pardo; A Pederson; J Petkovic; L Puil; L Quinlan; B Shea; T Rader; V Runnels; S Tudiver
Journal:  Res Integr Peer Rev       Date:  2017-09-01

Review 8.  Wound Healing and the Use of Medicinal Plants.

Authors:  Aleksandra Shedoeva; David Leavesley; Zee Upton; Chen Fan
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-22       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.